Cargando…

PCSK9 Promotes Cardiovascular Diseases: Recent Evidence about Its Association with Platelet Activation-Induced Myocardial Infarction

Cardiovascular diseases are the leading cause of death worldwide, with the majority of the cases being heart failure due to myocardial infarction. Research on cardiovascular diseases is currently underway, particularly on atherosclerosis prevention, to reduce the risk of myocardial infarction. Propr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puteri, Meidi Utami, Azmi, Nuriza Ulul, Kato, Mitsuyasu, Saputri, Fadlina Chany
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875594/ https://www.ncbi.nlm.nih.gov/pubmed/35207479 http://dx.doi.org/10.3390/life12020190

Ejemplares similares

Recent Update on PCSK9 and Platelet Activation Experimental Research Methods: In Vitro and In Vivo Studies
por: Puteri, Meidi Utami, et al.
Publicado: (2022)

High-Fat Diet Enhances Platelet Activation and Is Associated with Proprotein Convertase Subtilisin Kexin 9: An Animal Study
por: Saputri, Fadlina Chany, et al.
Publicado: (2023)

Brazilin from Caesalpinia sappan L. as a Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor: Pharmacophore-Based Virtual Screening, In Silico Molecular Docking, and In Vitro Studies
por: Iqbal, Muhammad, et al.
Publicado: (2023)

Platelet Glycoprotein-Ib (GPIb) May Serve as a Bridge between Type 2 Diabetes Mellitus (T2DM) and Atherosclerosis, Making It a Potential Target for Antiplatelet Agents in T2DM Patients
por: Amalia, Muttia, et al.
Publicado: (2023)

The neuroprotective potential of turmeric rhizome and bitter melon on aspartame-induced spatial memory impairment in rats
por: Suswidiantoro, Vicko, et al.
Publicado: (2023)

Effects of Hibiscus Sabdariffa Calyces Aqueous Extract on the Antihypertensive Potency of Captopril in the Two-Kidney-One-Clip Rat Hypertension Model
por: Nurfaradilla, Shinta Ayu, et al.
Publicado: (2019)

Pharmacokinetic Herb-Drug Interaction between Hibiscus sabdariffa Calyces Aqueous Extract and Captopril in Rats
por: Nurfaradilla, Shinta Ayu, et al.
Publicado: (2020)

Peperomia pellucida (L.) Kunth as an angiotensin-converting enzyme inhibitor in two-kidney, one-clip Goldblatt hypertensive rats
por: Saputri, Fadlina Chany, et al.
Publicado: (2021)

Optimization of choline chloride-glycerol based natural deep eutectic solvent for extraction bioactive substances from Cinnamomum burmannii barks and Caesalpinia sappan heartwoods
por: Sakti, Aditya Sindu, et al.
Publicado: (2019)

Current updates on protein as biomarkers for diabetic kidney disease: a systematic review
por: Sauriasari, Rani, et al.
Publicado: (2021)

TGF-β-Induced TMEPAI Attenuates the Response of Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel
por: Wardhani, Bantari WK, et al.
Publicado: (2020)

Correlation between Chemical Composition of Curcuma domestica and Curcuma xanthorrhiza and Their Antioxidant Effect on Human Low-Density Lipoprotein Oxidation
por: Jantan, Ibrahim, et al.
Publicado: (2012)

Inhibition of pancreatic elastase in silico and in vitro by Rubus rosifolius leaves extract and its constituents
por: Desmiaty, Yesi, et al.
Publicado: (2020)

Optimization of betaine-sorbitol natural deep eutectic solvent-based ultrasound-assisted extraction and pancreatic lipase inhibitory activity of chlorogenic acid and caffeine content from robusta green coffee beans
por: Ahmad, Islamudin, et al.
Publicado: (2021)

PMEPA1/TMEPAI Is a Unique Tumorigenic Activator of AKT Promoting Proteasomal Degradation of PHLPP1 in Triple-Negative Breast Cancer Cells
por: Haque, Md. Anwarul, et al.
Publicado: (2021)

Simultaneous Natural Deep Eutectic Solvent-Based Ultrasonic-Assisted Extraction of Bioactive Compounds of Cinnamon Bark and Sappan Wood as a Dipeptidyl Peptidase IV Inhibitor
por: Ahmad, Islamudin, et al.
Publicado: (2020)

Two triterpenoids from Rubus fraxinifolius leaves and their tyrosinase and elastase inhibitory activities
por: Desmiaty, Yesi, et al.
Publicado: (2021)

Circulating PCSK9 and Risk of Myocardial Infarction: The HUNT Study in Norway
por: Laugsand, Lars E., et al.
Publicado: (2016)

PCSK9 in Myocardial Infarction and Cardioprotection: Importance of Lipid Metabolism and Inflammation
por: Andreadou, Ioanna, et al.
Publicado: (2020)

Role of urinary H(2)O(2), 8-iso-PGF(2)α, and serum oxLDL/β2GP1 complex in the diabetic kidney disease
por: Sauriasari, Rani, et al.
Publicado: (2022)

Sex Differences Associated With Circulating PCSK9 in Patients Presenting With Acute Myocardial Infarction
por: Zhang, Zhong, et al.
Publicado: (2019)

PCSK9 Modulates Macrophage Polarization-Mediated Ventricular Remodeling after Myocardial Infarction
por: Wang, Feifei, et al.
Publicado: (2022)

Pcsk9 is associated with severity of coronary artery lesions in male patients with premature myocardial infarction
por: Gao, Jing, et al.
Publicado: (2021)

Plasma PCSK9 Levels Are Elevated with Acute Myocardial Infarction in Two Independent Retrospective Angiographic Studies
por: Almontashiri, Naif A. M., et al.
Publicado: (2014)

In-hospital initiation of PCSK9 inhibitor and short-term lipid control in patients with acute myocardial infarction
por: Lou, Bowen, et al.
Publicado: (2022)

Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Deletion but Not Inhibition of Extracellular PCSK9 Reduces Infarct Sizes Ex Vivo but Not In Vivo
por: Schreckenberg, Rolf, et al.
Publicado: (2022)

PCSK9 and Other Metabolic Targets to Counteract Ischemia/Reperfusion Injury in Acute Myocardial Infarction and Visceral Vascular Surgery
por: Ortona, Silvia, et al.
Publicado: (2022)

Blood lipid-related low-frequency variants in LDLR and PCSK9 are associated with onset age and risk of myocardial infarction in Japanese
por: Tajima, Tomoyuki, et al.
Publicado: (2018)

Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction
por: Ueland, Thor, et al.
Publicado: (2018)

Role of PCSK9 in the course of ejection fraction change after ST‐segment elevation myocardial infarction: a pilot study
por: Miñana, Gema, et al.
Publicado: (2020)

Effect of PCSK9 Inhibitor on Contrast-Induced Acute Kidney Injury in Patients with Acute Myocardial Infarction Undergoing Intervention Therapy
por: Ma, Yu, et al.
Publicado: (2022)

Independent association of PCSK9 with platelet reactivity in subjects without statin or antiplatelet agents
por: Wang, Shuai, et al.
Publicado: (2022)

Association of serum PCSK9 levels with platelet function in patients with acute coronary syndromes
por: Wang, Wenting, et al.
Publicado: (2023)

The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function
por: Di Costanzo, Assunta, et al.
Publicado: (2023)

FOURIER & PCSK9 RNAi: Towards enhancing durability and efficacy of PCSK9 inhibitors
por: Hassan, Mohamed
Publicado: (2017)

The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol
por: Seidah, Nabil G.
Publicado: (2017)

The Multifaceted Biology of PCSK9
por: Seidah, Nabil G, et al.
Publicado: (2021)

PCSK9 inhibitor valuation: A science‐based review of the two recent models
por: Baum, Seth J., et al.
Publicado: (2018)

Interpreting the Findings From the Recent PCSK9 Monoclonal Antibody Cardiovascular Outcomes Trials
por: Wong, Nathan D., et al.
Publicado: (2019)

Recent Advances on the Roles of PCSK-9 Inhibitors in the Management of Acute Ischemic Stroke Patients
por: Ilut, Silvina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sbt8fic69kp9nia66gnmu3nv19